7-27245053-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001304519.2(EVX1):c.-114G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000478 in 1,609,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001304519.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVX1 | ENST00000496902.7 | c.433G>T | p.Gly145Cys | missense_variant | Exon 2 of 3 | 1 | NM_001989.5 | ENSP00000419266.3 | ||
EVX1 | ENST00000222761.7 | c.378G>T | p.Pro126Pro | synonymous_variant | Exon 2 of 3 | 1 | ENSP00000222761.3 | |||
EVX1 | ENST00000580535.1 | c.93G>T | p.Pro31Pro | synonymous_variant | Exon 3 of 4 | 2 | ENSP00000463759.1 | |||
EVX1-AS | ENST00000517726.1 | n.269+1908C>A | intron_variant | Intron 1 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000576 AC: 14AN: 243238Hom.: 0 AF XY: 0.0000754 AC XY: 10AN XY: 132666
GnomAD4 exome AF: 0.0000473 AC: 69AN: 1457590Hom.: 0 Cov.: 32 AF XY: 0.0000441 AC XY: 32AN XY: 725112
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.433G>T (p.G145C) alteration is located in exon 2 (coding exon 2) of the EVX1 gene. This alteration results from a G to T substitution at nucleotide position 433, causing the glycine (G) at amino acid position 145 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at